JANUMET - 0006-0575-52 - (SITAGLIPTIN and METFORMIN HYDROCHLORIDE)

Alphabetical Index


Drug Information of JANUMET

Product NDC: 0006-0575
Proprietary Name: JANUMET
Non Proprietary Name: SITAGLIPTIN and METFORMIN HYDROCHLORIDE
Active Ingredient(s): 500; 50    mg/1; mg/1 & nbsp;   SITAGLIPTIN and METFORMIN HYDROCHLORIDE
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of JANUMET

Product NDC: 0006-0575
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022044
Marketing Category: NDA
Start Marketing Date: 20070330

Package Information of JANUMET

Package NDC: 0006-0575-52
Package Description: 5 BLISTER PACK in 1 CARTON (0006-0575-52) > 10 TABLET, FILM COATED in 1 BLISTER PACK (0006-0575-01)

NDC Information of JANUMET

NDC Code 0006-0575-52
Proprietary Name JANUMET
Package Description 5 BLISTER PACK in 1 CARTON (0006-0575-52) > 10 TABLET, FILM COATED in 1 BLISTER PACK (0006-0575-01)
Product NDC 0006-0575
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name SITAGLIPTIN and METFORMIN HYDROCHLORIDE
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20070330
Marketing Category Name NDA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
Strength Number 500; 50
Strength Unit mg/1; mg/1
Pharmaceutical Classes Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient]

Complete Information of JANUMET


General Information